XJSE
LHC
Market cap1.04bUSD
Oct 09, Last price
1,218.00ZAR
1D
0.25%
1Q
12.47%
Jan 2017
-59.84%
Name
Life Healthcare Group Holdings Ltd
Chart & performance
P/E
4.51
P/S
0.69
EPS
2.70
Div yield, %
28.92%
Shrs. gr., 5y
-0.09%
Rev. gr., 5y
-0.22%
Revenues
25.10b
-1.63%
Net income
3.86b
-19.95%
CFO
3.85b
+3.52%
Dividend
Jun 17, 202623 ZAR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Johannesburg, South Africa, Life Healthcare Group Holdings Limited, established in 1983, operates as a prominent international provider of private hospital services. Its extensive operations span South Africa, Canada, the United Kingdom, various other European countries, and broader international markets. The company's business is structured into two principal divisions: Hospitals and Complementary Services, and Healthcare Services. It delivers a comprehensive range of acute hospital care alongside diverse complementary offerings. These include the specialized services of Life Esidimeni, which covers chronic mental healthcare, frail care, rehabilitation, step-down facilities, correctional healthcare, primary care, and substance abuse recovery programs. Additionally, its Life Employee Health Solutions segment provides on-site occupational health, primary healthcare, and employee wellness initiatives. The company's medical expertise extends across numerous fields, such as diagnostics, mental health treatment, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedics, pediatrics, dermatology, ophthalmology, gynecology, and obstetrics. Furthermore, Life Healthcare is involved in advanced diagnostic imaging, operating magnetic resonance imaging (MRI) and computerized tomography (CT) scanners, and both developing and distributing radiopharmaceuticals vital for positron emission tomography-computerized tomography (PET-CT) diagnostics. The organization was formerly known as Afrox Healthcare Limited until its name change to Life Healthcare Group Holdings Limited in January 2005.
Related entities
Subsidiaries
Life Healthcare Funding Limited
Key people
Non-Executive Chairman of the Board · since 2013
Pieter P. van der Westhuizen
Acting Group Chief Executive Officer, Group Chief Financial Officer · since 2020
Mark Chapman
Chief Executive Officer - International · since 2019
Adam Pyle
Chief Executive Officer � South Africa and Group Investor Relations Executive · since 2018
Shrey Viranna
Group Chief Executive Officer, Executive Director · since 2018
Suren Govender
Group Chief Digital Officer · since 2019
Tanya Little
Group Operations Executive · since 2019
Brett Mill
Executive - Group Strategic Planning · since 2018
Avanthi Parboosing
Group Company Secretary · since 2019
Peter J. Golesworthy
Lead Independent Non - Executive Director · since 2014
Guy Blomfield
Non-Executive Director · since 2018
Marian E. Jacobs
Independent Non-Executive Director · since 2014
Victor Litlhakanyane
Non-Executive Independent Director · since 2020
Audrey Mothupi
Independent Non-Executive Director · since 2017
Independent Non-Executive Director · since 2010
Malefetsane Peter Ngatane
Independent Non-Executive Director · since 2007
Garth C. Solomon
Independent Non-Executive Director · since 2014
Royden Thomas Vice
Independent Non-Executive Director · since 2014
Headquarters & legal address
21 OXFORD, MANOR RUDD AND CHAPLIN ROADS
Illovo, KZN 2196
ZA
Illovo, KZN 2196
ZA
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||